{
    "eid": "2-s2.0-84929439825",
    "title": "Phenytoin toxicity in two-month-old Thai infant with CYP2C9 gene polymorphism - A case report",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Pediatrics",
            "@code": "2735"
        },
        {
            "$": "Neurology (clinical)",
            "@code": "2728"
        },
        {
            "$": "Developmental Neuroscience",
            "@code": "2806"
        }
    ],
    "keywords": [
        "CYP2C9 gene polymorphism",
        "Infant",
        "Phenytoin toxicity"
    ],
    "authors": [
        "Montida Veeravigrom"
    ],
    "citedby-count": 5,
    "ref-count": 4,
    "ref-list": [
        "Oral dosing requirements for phenytoin in the first three months of life",
        "CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population",
        "Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs",
        "Unusual presentation of iatrogenic phenytoin toxicity in a newborn."
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}